Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

This study has been completed.
Sponsor:
Collaborator:
Abbott
Information provided by:
Saint Michael's Medical Center
ClinicalTrials.gov Identifier:
NCT00752037
First received: September 12, 2008
Last updated: July 19, 2011
Last verified: September 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)